pyrimethamine has been researched along with Cancer of Pituitary in 1 studies
Maloprim: contains above 2 cpds
Excerpt | Relevance | Reference |
---|---|---|
"Invasive pituitary adenomas (PAs) are generally refractory to conventional therapy and salvage treatment with temozolomide (TMZ)." | 1.39 | Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways. ( Bao, X; Cai, F; Dai, C; Deng, K; Feng, M; Guo, K; Jiao, Y; Junji, W; Lian, W; Liu, X; Ma, S; Wang, R; Wei, Z; Xing, B; Yang, Y; Yao, Y; Zhang, B, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dai, C | 1 |
Zhang, B | 1 |
Liu, X | 1 |
Guo, K | 1 |
Ma, S | 1 |
Cai, F | 1 |
Yang, Y | 1 |
Yao, Y | 1 |
Feng, M | 1 |
Bao, X | 1 |
Deng, K | 1 |
Jiao, Y | 1 |
Wei, Z | 1 |
Junji, W | 1 |
Xing, B | 1 |
Lian, W | 1 |
Wang, R | 1 |
1 other study available for pyrimethamine and Cancer of Pituitary
Article | Year |
---|---|
Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspas | 2013 |